Member Info for Rooky

All this RNS is stating that the options are being accepted as a fare grant.

The problem as I think we all agree, was not the actual granting of those options as they came under its existing share incentive scheme, it was the actions taken re following RNS's.

MisterPosative,

Thanks, will give Investing.com a try

Is anyone else having a problem with there portfolio on this site.

Mine is often thousands of pounds out, with the PHE stock causing the problem, as at close my daily profit is exactly my total holdings being converted into pence, IE 500,004 shares held converting to £5,000.04p

III have made several attempt to fix it, to no avail, so if anyone can recommend the best free site to keep my portfolio figures on, it would be appreciated.

Regards Rooky.

As been mentioned on here before, Dr Cave is not financially savvy re Stock Market rules, and when he mentioned sales in his video, he was being a bit naïve re those rules and was presumably quickly advised, this is in no way a criticism of him.

I am sure that sales have been agreed, and probably contracts drawn up and signed, containing the proviso of full accreditations, plus all required tests passed.

The Liquidnano mask will eradicate over 98% of coronavirus on contact within 1 hour (rising to 99.9% after 4 hours) thereby reducing the risk of contact transmission.

That is nothing like a claim that it kills the virus on contact, only that the virus requires contact with the mask for 1 hour to kill 98% of the virus.

If you wear a Liquidnano mask, just imagine waiting for 1 hour for the mask to kill the Covid virus after it reaches your mask/face and the harm it can do in that time.

Can't see any point in such a mask whatsoever.

PHE stated years ago that they would expect the obtaining plastic as a feed stock would/should be either a no cost price or even at a price paid to them, due to the high cost of getting the material to storage/disposal sites.

Whilst excepting that PHE is not in the business of selling hydrogen, I would not call any discussion re cost a 'red herring' as the cost of hydrogen produced by the PHE DMG, will always play a part.

Hydrogen via the DMG process, lower than other methods will always mean more demand in DMGs, higher than the DMG process, less demand.

Of course the balance with it being a green process, plus the cheaper disposal of plastics will play a part

Every PI investor in PHE should listen to this interview.

No rambling, just direction of where the company is headed.

The main items mentioned, points to a good profitable 2021, and even better years to follow.

Jarus,

A good question.

The answer is bureaucracy, bureaucracy and more bureaucracy.

Chance should read change.

The appointment of Tim Irish as a Director of Deltex Medical looks to be a move that should help the company to start moving out of first gear to moving quicker (they couldn't be moving much slower) .
I like his connection with NICE 'Tim's current appointments cover life sciences and healthcare, both public and private, including his Board role at NICE where he is Vice Chair'.

I appreciate Covid knocked the company back just as it was looking to progress.

Bumble35,

Agree the low volumes, but as for investors piling in if the company was better known, I doubt it, as all investors would need to do is look at the snail like progress over the years.

The technology, still looks great, in fact improved over the last couple of years, and yet they still appear almost static on sales (allowing for Covid).

So investing into the technology, yes, but investing into the companies history of progress, no, although the new director might just chance this.

The reasons why are a mystery to me.

Just wondering if there was a time line set for free use, as I am sure that no one expected the Covid situation to last for so long.

I may have read it wrong but, even if no time limit, I could only find that the roll out to assist was taking place at a single hospital trust (Pennine Hospital Trust) which is the trust where the Bleepa pilot was being carried out.

See below,

Owing to the immense workforce pressures facing the clinical frontline at this time, Feedback and Pennine NHS Trust have elected to pause the Bleepa pilot, which was focusing on evaluating specific clinical workflow applications of Bleepa, and are now evaluating options for a wider rollout to support the local COVID-19 response at the Trust. It is hoped that this solution will subsequently be rolled out to other centres.

Note the valuation options do not state full supply, so to my mind it points to several such Bleepa's for valuation purposes.

Surely orders must follow quickly, as I feel security was probably a question being asked by potential customers.

The next couple of months will show if this company is firmly set for the future, and I am very positive following todays news.

Just seen the latest contribution from Mervvv.

Not Much [point in keeping him off ignore.

Last few days there have been several very informative and interesting posts, and I don't want to waste time wading through rubbish.

Haggis,

Why bother taking the bait cast by Mervvv,

We all know who has contributed more to this thread, and how new to it Mervvv is, but if you bite, especially using derogatory language (we can guess the words not fully completed) you only let yourself down.

Not yet putting Mervvv on ignore, until I see a few more posts to judge on.

Tried twice to buy, but trades not accepted, so for the first time ever, had to put in a buy limit order.

The last test is the biocompatibility test, which tests the reaction to human skin - cytotoxicity, irritation and sensitization. This test has been delayed and is now expected to be completed in the next week.

This was obviously going to be the last test, as there's no point in such a test until the others have passed, just in case anything mask material had to be altered,

No worry there at all.

DrAnomaly,

Good concise reply, shame BlueToff had to be both insulting and unhelpful to Qualia144, as to me his post was a straight quirey, neither a ramp or de-ramp.

Even as a LTH, if I had not made lists of bullet points, I would find it difficult to remember all relevant aspects mentioned re both IP and Patents.

Due to the hauling over the coals of late re some board members, I doubt very much that they would dare hide any bad news, such as machine delay, machine malfunction, initial production roll out failing, ect ect as with the sp steadily climbing, it would as before leave them wide open to criticism and possible market authority action.

That to me sends a silent message, that all is well (albeit any slight delays) and that they are waiting to announce several positives all at once, production line up and running, first batch being completed, tested and CE certified.

Followed by order numbers, after all, who invested is going to complain, if such news is released within the next 5 trading days.

Of course, I could be completely wrong, its just that on previous form I cant see the board taking further risks in what they release to investors.

Two late reported trade, registered as sells, both actually buys.

14-Jan-21 15:34:03 81.20 50,000 Sell* 81.40 79.30 40.60k
14-Jan-21 15:31:09 81.62 40,000 Sell* 81.40 79.30 32.65k

Although a great RNS as another line to the global net that AFC are joining, I think a breach of £1 won't happen today, due to the main news investors are waiting for is a supply contact note.

That is not a moan, as I strongly believe all these collaboration's will pay very well within the next 12 months.